Featured Editorial
Raising The Bar: The Silver Lining Of FDA Commissioner Gottlieb’s Exit
 
By Nancy Bradish Myers, Catalyst Healthcare Consulting, Inc.

It was the announcement many have been dreading — but expecting — for several months now. Dr. Scott Gottlieb, 23rd Commissioner of the FDA, announced his decision to step down after 663 days (22 months) on the job. The news is sure to raise concerns for many. But I think the biggest surprise is how equally sad thought-leaders within the agency will be to say goodbye.

Industry Insights
Optimize Biologic Drug Development With The Power Of Scientific Informatics
Webinar | Dassault Systemes Americas

The complex structure of Biologics, the nature of the interactions with their partners, require accurate modelling method to predict their physicochemical properties.

Solutions
Industry 4.0 - From Vision To Reality
Festo Corporation
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.